Search results for "Atrioventricular block"

showing 10 items of 20 documents

The Role of Cardiac Pacing in Heart Block Complicating Acute Myocardial Infarction

1983

The organization of the Coronary Care Unit and the use of electrocardiographic monitoring have allowed a re-evaluation of the incidence of the atrioventricular conduction disturbances in acute myocardial infarction.

medicine.medical_specialtyCardiac pacingHeart blockbusiness.industryIncidence (epidemiology)Electrocardiography in myocardial infarctionmedicine.diseaseInternal medicinecardiovascular systemmedicineCardiologyCoronary care unitcardiovascular diseasesMyocardial infarctionbusinessAtrioventricular conduction disturbancesAtrioventricular block
researchProduct

Chronic Apical and Nonapical Right Ventricular Pacing in Patients with High-Grade Atrioventricular Block: Results of the Right Pace Study

2018

Objective. The aim of the study was to compare the two approaches to chronic right ventricular pacing currently adopted in clinical practice: right ventricular apical (RVA) and non-RVA pacing. Background. Chronic RVA pacing is associated with an increased risk of atrial fibrillation, morbidity, and even mortality. Non-RVA pacing may yield more physiologic ventricular activation and provide potential long-term benefits and has recently been adopted as standard procedure at many implanting centers. Methods. The Right Pace study was a multicenter, prospective, single-blind, nonrandomized trial involving 437 patients indicated for dual-chamber pacemaker implantation with a high percentage of RV…

Genetics and Molecular Biology (all)Malemedicine.medical_specialtyArticle SubjectImmunology and Microbiology (all)Heart Ventricleslcsh:Medicine030204 cardiovascular system & hematologyBiochemistryGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciences0302 clinical medicineInternal medicinemedicine80 and overHumansIn patientSingle-Blind Method030212 general & internal medicineInterventricular septumProspective StudiesAtrioventricular BlockAgedAged 80 and overGeneral Immunology and Microbiologybusiness.industrylcsh:RCardiac Pacing ArtificialReproducibility of ResultsAtrial fibrillationGeneral MedicineVentricular pacingmedicine.diseaseIncreased riskmedicine.anatomical_structureHigh grade atrioventricular blockTreatment OutcomeBaseline characteristicsHeart failureArtificialCardiologyClinical StudyQuality of LifeCardiac PacingFemalebusinessAged; Aged 80 and over; Female; Heart Ventricles; Humans; Male; Prospective Studies; Quality of Life; Reproducibility of Results; Single-Blind Method; Treatment Outcome; Atrioventricular Block; Cardiac Pacing Artificial; Biochemistry Genetics and Molecular Biology (all); Immunology and Microbiology (all)BioMed Research International
researchProduct

BASCULE syndrome associated with presyncopal episodes and first‐degree atrioventricular block

2021

medicine.medical_specialtybusiness.industryMEDLINESyndromeDermatologymedicine.diseaseElectrocardiographyText miningFirst-degree atrioventricular blockInternal medicinemedicineCardiologyHumansAtrioventricular BlockbusinessInternational Journal of Dermatology
researchProduct

Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial

2014

BACKGROUND: In patients with relapsing-remitting MS (RRMS) fingolimod prevents disease relapses and delays disability progression. First dose administration of fingolimod is associated with a transient, dose-dependent decrease in heart rate (HR) in the 6 hours after drug intake.The aim of the study is to to assess safety and tolerability of the first dose of fingolimod in a cohort of Italian patients with RRMS without alternative therapeutic options. METHODS: Open-label, single arm, multicentre study. After the first dose of fingolimod, patients were observed for 6 hours and had their vital signs monitored hourly. Extended on-site monitoring was provided when required. RESULTS: Of the 906 p…

OncologyMaleNeurologyfingolimod multiple sclerosis treatment first dose safetyadministration /&/ dosage/adverse effects/analogs /&/ derivatives/therapeutic useImmunosuppressive AgentSphingosineMultiple SclerosiAtrioventricular Blockadministration /&/ dosage/adverse effects/therapeutic useGeneral MedicineMiddle AgedTolerabilityPropylene GlycolFingolimoddrug therapyTolerabilityAnesthesiaCohortAdolescent Adult Atrioventricular Block; chemically induced/epidemiology Drug Therapy; Combination Female Humans Immunosuppressive Agents; administration /&/ dosage/adverse effects/therapeutic use Male Middle Aged Multiple Sclerosis; drug therapy Propylene Glycols; administration /&/ dosage/adverse effects/therapeutic use Sphingosine; administration /&/ dosage/adverse effects/analogs /&/ derivatives/therapeutic use Young AdultCombinationDrug Therapy CombinationSettore MED/26 - NeurologiaFemaleAtrioventricular block; Bradycardia; Fingolimod; Multiple sclerosis; Safety; Tolerability; Adolescent; Adult; Atrioventricular Block; Drug Therapy Combination; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis; Propylene Glycols; Sphingosine; Young Adult; Neurology (clinical)SafetyAtrioventricular block Bradicardia Multiple sclerosis Fingolimod Safety TolerabilityImmunosuppressive AgentsResearch ArticleHumanmedicine.drugAdultmedicine.medical_specialtyMultiple SclerosisAdolescentClinical NeurologyYoung AdultFingolimod HydrochlorideInternal medicineBradycardiamedicineHumansNeurochemistryFingolimod Hydrochloridebusiness.industryMultiple sclerosisFingolimodmedicine.diseaseClinical trialPropylene GlycolsAtrioventricular block Bradycardia Multiple sclerosis Fingolimod Safety Tolerabilitychemically induced/epidemiologyNeurology (clinical)business
researchProduct

A G613A missense in the Hutchinson's progeria lamin A/C gene causes a lone, autosomal dominant atrioventricular block.

2014

Background LMNA/C mutations have been linked to the premature aging syndrome Hutchinson’s progeria, dilated cardiomyopathy 1A, skeletal myopathies (such as the autosomal dominant variant of Emery-Dreifuss muscular dystrophy and limb-girdle muscular dystrophy), Charcot-Marie-Tooth disorder type 2B1, mandibuloacral dysplasia, autosomal dominant partial lipodystrophy, and axonal neuropathy. Atrioventricular block (AVB) can be associated with several cardiac disorders and it can also be a highly heritable, primitive disease. One of the most common pathologies associated with AVB is dilated cardiomyopathy (DCM), which is characterized by cardiac dilatation and reduced systolic function. In this …

ProbandGeneticsExome sequencingAgingProgeriaLamin A/Cbusiness.industryResearchImmunologyDilated cardiomyopathymedicine.diseaseSudden deathLMNAMandibuloacral dysplasiaAgeingMedicineMissense mutationMuscular dystrophybusinessExome sequencingArrhythmiaAtrioventricular blockImmunityageing : IA
researchProduct

A second-degree atrioventricular block with double escape rhythm secondary to paroxysmal vagal hypertonia.

2017

medicine.diagnostic_testbusiness.industryVagus NerveGeneral Medicine030204 cardiovascular system & hematologyMiddle Agedmedicine.diseaseVagus nerve03 medical and health sciencesElectrocardiography0302 clinical medicineRhythmAnesthesiaMedicineHypertoniaHumans030212 general & internal medicinemedicine.symptomCardiology and Cardiovascular MedicinebusinessAtrioventricular BlockAtrioventricular blockElectrocardiographySecond-degree atrioventricular blockJournal of cardiovascular medicine (Hagerstown, Md.)
researchProduct

P and R Wave Detection in Complete Congenital Atrioventricular Block

2009

Complete atrioventricular block (type III AVB) is characterized by an absence of P wave transmission to ventricles. This implies that QRS complexes are generated in an autonomous way and are not coordinated with P waves. This work introduces a new algorithm for the detection of P waves for this type of pathology using non-invasive electrocardiographic surface leads. The proposed algorithm is divided into three stages. In the first stage, the R waves located by a QRS detector are used to generate the RR series and time references for the other stages of the algorithm. In the second stage, the ventricular activity (QT segment) is removed by using an adaptive filter that obtains an averaged pa…

AdultAdolescentBiomedical EngineeringYoung AdultQRS complexHeart Conduction SystemmedicineHumansSensitivity (control systems)Atrioventricular BlockChildMathematicsSeries (mathematics)P waveDetectorSignal Processing Computer-Assistedmedicine.diseaseAdaptive filterTransmission (telecommunications)Child PreschoolElectrocardiography AmbulatoryEnginyeria biomèdicaAtrioventricular blockAlgorithmAlgorithmsAnnals of Biomedical Engineering
researchProduct

First-degree atrioventricular block and pseudopacemaker syndrome

2013

MalePacemaker Artificialmedicine.medical_specialtySystoleVena Cava InferiorInferior vena cavaVentricular Function LeftHeart RateInternal medicinemedicineHumansCardiac OutputAtrioventricular BlockAged 80 and overBloc atrioventriculaire du premier degrébusiness.industryCardiac Pacing ArtificialHemodynamicsSynchronisme atrioventriculaireGeneral MedicineFirst degree AV blockmedicine.diseaseEchocardiography DopplerPacemakerFirst-degree AV blockStimulateur cardiaqueTreatment Outcomemedicine.veinRegional Blood FlowFirst-degree atrioventricular blockElectrocardiography AmbulatoryCardiologyAV synchronyCardiology and Cardiovascular MedicinebusinessAtrioventricular blockArchives of Cardiovascular Diseases
researchProduct

Die Wirkung von Ouabain auf die Elimination von Noradrenalin aus der Perfusionsfl�ssigkeit des isolierten Kaninchenherzens

1966

Isolated rabbit hearts were perfused with Tyrode solution containing 10 ng/ml (-)-noradrenaline for 20 min. The uptake by the heart of noradrenaline was calculated by estimating the percentage of amine removed from the perfusion fluid during a single passage through the heart. Previous experiments have shown that the amount of noradrenaline removed from the perfusion fluid corresponds well to the amount retained by the heart. In control experiments, the mean removal (elimination) of noradrenaline was 50±1.7% of the amount infused as measured biologically and 46±2.2% as measured fluorimetrically. Ouabain was added to the perfusion fluid at concentrations ranging from 2.74·10−7 to 2.0·10−6 mo…

PharmacologyInotropemedicine.medical_specialtyPotassiumNoradrenaline transportSodiumchemistry.chemical_elementGeneral Medicinemedicine.diseaseOuabainCell membraneEndocrinologymedicine.anatomical_structurechemistryInternal medicineMolemedicineAtrioventricular blockmedicine.drugNaunyn-Schmiedebergs Archiv f�r Pharmakologie und Experimentelle Pathologie
researchProduct

Chronisches thromboembolisches Cor pulmonale bei schrittmacherassoziierten rechtsatrialen Thromben: Pulmonale Thrombendarteriektomie mit Elektrodenen…

2008

Life-threatening chronic cor pulmonale occurred in a 22-year-old woman with congenital 3 degrees atrioventricular block, 6 years after implantation of a pacemaker and 3 1/2 years after removal of the pacemaker (the electrodes were too firmly attached to be removed). The emboli originated from the right-atrial thrombi which had formed around the electrodes left in situ. The embolic source shrank during systemic administration of urokinase, initially 600,000 IU in 60 min, then 100,000 IU per hour, and pulmonary perfusion improved transiently. Nonetheless the patient became breathless on the slightest physical exertion. Recurrent syncopal attacks with marked increase of pulmonary artery pressu…

Urokinasemedicine.medical_specialtyPulmonary thromboendarterectomybusiness.industrymedicine.medical_treatmentGeneral Medicinemedicine.diseaseRight atrialInternal medicinemedicine.arteryPulmonary arterymedicineCardiologyExertionbusinessAtrioventricular blockPerfusionmedicine.drugEndarterectomyDMW - Deutsche Medizinische Wochenschrift
researchProduct